Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;3(6):466-471.
doi: 10.1016/j.jpha.2013.05.002. Epub 2013 Jun 3.

Rapid sensitive validated UPLC-MS method for determination of venlafaxine and its metabolite in rat plasma: Application to pharmacokinetic study

Affiliations

Rapid sensitive validated UPLC-MS method for determination of venlafaxine and its metabolite in rat plasma: Application to pharmacokinetic study

Sunil Kumar Dubey et al. J Pharm Anal. 2013 Dec.

Abstract

A new ultra-performance liquid chromatography-electrospray ionization mass spectrometry (UPLC-MS/ESI) method for simultaneous determination of venlafaxine (VEN) and its metabolite O-desmethylvenlafaxine (ODV) in rat plasma has been developed and validated using Venlafaxine d6 as the internal standard. The compounds and internal standard were extracted from plasma by solid phase extraction. The UPLC separation of the analytes was performed on ACQUITY UPLC® BEH Shield RP18 (1.7 µm, 100 mm×2.1 mm) column, using isocratic elution with mobile phase constituted of water (containing 2 mM ammonium acetate): acetonitrile (20:80, v/v) at a flow rate of 0.3 mL/min. All of the analytes were eluted within 1.5 min. The compounds were ionized in the electrospray ionization (ESI) ion source of the mass spectrometer, operating in multiple reaction monitoring (MRM) and positive ion mode. The precursor to product ion transitions monitored for VEN, ODV and Venlafaxine d6 were m/z 278.3→121.08, 264.2→107.1 and 284.4→121.0, respectively. The developed and validated method was used for the pharmacokinetic study of VEN in rats.

Keywords: Metabolite; O-desmethylvenlafaxine; UPLC–MS/ES; Venlafaxine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chemical structure of each compound: Venlafaxine (VEN), O-desmethylvenlafaxine (ODV) and Venlafaxine d6.
Fig. 2
Fig. 2
Representative chromatograms of (A) VEN, (B) ODV and (C) Venlafaxine d6.
Fig. 3
Fig. 3
Plasma concentration–time profile of VEN and ODV after oral administration of 30 mg/kg of venlafaxine hydrochloride in rats.
None

Similar articles

Cited by

References

    1. Andrews J.M., Ninan P.T., Nemeroff C.B. Venlafaxine: a novel antidepressant that has a dual mechanism of action. Depression. 1996;4:48–56. - PubMed
    1. Hicks D.R., Wolaniuk D., Russell A. A high-performance liquid chromatographic method for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in biological fluids. Ther. Drug Monit. 1994;16:100–107. - PubMed
    1. Deecher D.C., Beyer C.E., Johnston G. Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor. J. Pharmacol. Exp. Ther. 2006;318:657–665. - PubMed
    1. Fogelman S.M., Schmider J., Venkatakrishnan K. O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants. Neuropsychopharmacology. 1999;20:480–490. - PubMed
    1. Tzanakaki M., Guazzelli M., Nimatoudis I. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia. Int. Clin. Psychopharmacol. 2000;15:29–34. - PubMed